Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-17

Clinical Trial Update: Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis [NA]

View source ↗

Summary

A completed clinical trial comparing ingenol mebutate with 5-fluorouracil for the safety and tolerability of treating facial actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: University of Sao Paulo | Conditions: Actinic Keratosis | NA | Status: COMPLETED